drugset / Trial / NCT02578043

A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris

NCT02578043

Phase 1 Completed 844 enrolled Sun Pharmaceutical Industries, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The objectives of this study are to evaluate the therapeutic equivalence and safety.

Timeline

Start
2015-04
Primary completion
2015-08
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzoyl Peroxide Other / unclassified 3.75 % Topical
Subject Clindamycin Unknown 1.2 % Topical

Indications